Tirdzniecība Assertio Holdings, Inc. - ASRT CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.0460 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.024068% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | 0.001846% | ||||||||
Nakts laika nodeva | 21:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | USD | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | United States of America | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Iepriekš. aizvērt* | 5.7525 |
Atvērt* | 5.8921 |
Izmaiņas par 1 gadu* | 119.04% |
Dienas Diapazons* | 5.8921 - 6.0117 |
52 ned Diapazons | 1.86-7.00 |
Vidējais apjoms (10 dienas) | 3.34M |
Vidējais apjoms (3 mēneši) | 37.69M |
Tirgus Kapitalizācija | 324.02M |
Cenas/Peļņas Attiecība | 3.33 |
Izvietotās Akcijas | 55.58M |
Ieņēmumi | 156.23M |
EPS | 1.75 |
Dividende (Ienesīgums %) | N/A |
Beta | 1.38 |
Nākamās Peļņas Datums | May 8, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
Mar 20, 2023 | 5.7525 | -0.0299 | -0.52% | 5.7824 | 5.9320 | 5.7126 |
Mar 17, 2023 | 5.8024 | -0.3589 | -5.83% | 6.1613 | 6.1613 | 5.8024 |
Mar 16, 2023 | 6.2211 | 0.5783 | 10.25% | 5.6428 | 6.2909 | 5.5531 |
Mar 15, 2023 | 5.6528 | -0.0697 | -1.22% | 5.7225 | 5.8423 | 5.5731 |
Mar 14, 2023 | 5.8921 | 0.5484 | 10.26% | 5.3437 | 6.0516 | 5.3437 |
Mar 13, 2023 | 5.2241 | -0.3090 | -5.58% | 5.5331 | 5.5830 | 5.2141 |
Mar 10, 2023 | 5.7226 | -0.7676 | -11.83% | 6.4902 | 6.5402 | 5.6129 |
Mar 9, 2023 | 6.6399 | 0.6781 | 11.37% | 5.9618 | 6.9689 | 5.9418 |
Mar 8, 2023 | 5.9320 | -0.1794 | -2.94% | 6.1114 | 6.1414 | 5.7924 |
Mar 7, 2023 | 6.1414 | 0.1098 | 1.82% | 6.0316 | 6.2510 | 5.9020 |
Mar 6, 2023 | 6.0815 | -0.3589 | -5.57% | 6.4404 | 6.4504 | 6.0018 |
Mar 3, 2023 | 6.1912 | 0.3889 | 6.70% | 5.8023 | 6.3108 | 5.7126 |
Mar 2, 2023 | 5.7326 | -0.1695 | -2.87% | 5.9021 | 5.9120 | 5.7126 |
Mar 1, 2023 | 5.9320 | 0.3091 | 5.50% | 5.6229 | 5.9719 | 5.5829 |
Feb 28, 2023 | 5.5232 | 0.3291 | 6.34% | 5.1941 | 5.6030 | 5.1941 |
Feb 27, 2023 | 5.2341 | 0.0598 | 1.16% | 5.1743 | 5.2839 | 5.0646 |
Feb 24, 2023 | 5.1045 | 0.0997 | 1.99% | 5.0048 | 5.1244 | 4.8752 |
Feb 23, 2023 | 5.0447 | 0.0001 | 0.00% | 5.0446 | 5.1842 | 4.7555 |
Feb 22, 2023 | 5.3338 | 0.1994 | 3.88% | 5.1344 | 5.5332 | 5.0844 |
Feb 21, 2023 | 5.1643 | 0.1498 | 2.99% | 5.0145 | 5.2640 | 4.9647 |
Assertio Holdings, Inc. Events
Laiks (UTC) (UTC) | Valsts | Notikums |
---|---|---|
No events scheduled |
- Ikgadējs
- Ceturkšņa
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kopējie ienākumi | 111.014 | 106.275 | 229.504 | 311.77 | 380.724 |
Ienākumi | 111.014 | 106.275 | 229.504 | 311.77 | 380.724 |
Cost of Revenue, Total | 15.232 | 15.772 | 9.505 | 18.476 | 72.598 |
Bruto Peļņa | 95.782 | 90.503 | 219.999 | 293.294 | 308.126 |
Kopējie Darbības Izdevumi | 101.59 | 132.637 | 397.547 | 206.111 | 411.778 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 56.555 | 105.323 | 108.866 | 119.218 | 195.696 |
Pētniecība un Attīstība | 0 | 4.213 | 10.106 | 8.042 | 13.718 |
Depreciation / Amortization | 28.114 | 24.783 | 101.774 | 101.774 | 102.745 |
Neparedzēti Izdevumi (Ienākumi) | 1.689 | -17.454 | 167.296 | -41.399 | 27.021 |
Darbības Izdevumi | 9.424 | -26.362 | -168.043 | 105.659 | -31.054 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -10.22 | -15.926 | -58.389 | -68.881 | -73.552 |
Citi, Neto | 0.243 | -3.225 | 3.948 | 1.197 | 0.681 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -0.553 | -45.513 | -222.484 | 37.975 | -103.925 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -1.281 | -28.144 | -217.201 | 36.908 | -76.996 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -1.281 | -28.144 | -217.201 | 36.908 | -76.996 |
Neto Ienākumi | -1.281 | -28.144 | -217.201 | 36.908 | -102.496 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -1.281 | -28.144 | -217.201 | 36.908 | -76.996 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -1.281 | -28.144 | -217.201 | 36.908 | -102.496 |
Atšķaidīšanas Iestāstīšana | |||||
Atšķaidītie Neto Ienākumi | -1.281 | -28.144 | -217.201 | 36.908 | -102.496 |
Atšķaidītie Ienākumi par Akcijām | 43.169 | 26.2087 | 17.679 | 16.052 | 15.6756 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.02967 | -1.07384 | -12.2858 | 2.29928 | -4.91184 |
Atšķaidītā Normalizētā Peļņa par Akciju | -0.00424 | -1.50671 | -6.13488 | 0.62289 | -3.23543 |
Ārkārtas Posteņi Kopā | -25.5 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kopējie ienākumi | 36.538 | 33.328 | 25.472 | 25.373 | 26.839 |
Ienākumi | 36.538 | 33.328 | 25.472 | 25.373 | 26.839 |
Cost of Revenue, Total | 3.795 | 4.896 | 3.05 | 3.621 | 3.766 |
Bruto Peļņa | 32.743 | 28.432 | 22.422 | 21.752 | 23.073 |
Kopējie Darbības Izdevumi | 24.979 | 25.347 | 19.538 | 37.374 | 19.332 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 10.438 | 13.276 | 9.313 | 26.235 | 7.73 |
Pētniecība un Attīstība | 0 | 0 | 0 | 0 | |
Depreciation / Amortization | 8.701 | 7.175 | 7.175 | 7.218 | 6.547 |
Neparedzēti Izdevumi (Ienākumi) | 0.4 | 0 | 0 | 0.3 | 1.289 |
Darbības Izdevumi | 11.559 | 7.981 | 5.934 | -12.001 | 7.507 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -2.327 | -2.437 | -2.495 | -2.605 | -2.684 |
Citi, Neto | 0.545 | -0.504 | 0.344 | 0.137 | 0.269 |
Neto Ienākumi Pirms Nodokļu Nomaksas | 9.777 | 5.04 | 3.783 | -14.469 | 5.092 |
Neto Ienākumi Pēc Nodokļu Nomaksas | 9.064 | 4.606 | 3.737 | -14.169 | 4.544 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | 9.064 | 4.606 | 3.737 | -14.169 | 4.544 |
Neto Ienākumi | 9.064 | 4.606 | 3.737 | -14.169 | 4.544 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 9.064 | 4.606 | 3.737 | -14.169 | 4.544 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 9.064 | 4.606 | 3.737 | -14.169 | 4.544 |
Atšķaidītie Neto Ienākumi | 9.064 | 4.606 | 3.737 | -14.169 | 4.544 |
Atšķaidītie Ienākumi par Akcijām | 46.127 | 45.026 | 45.055 | 44.706 | 38.4795 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.1965 | 0.1023 | 0.08294 | -0.31694 | 0.11809 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | 0.20454 | 0.1023 | 0.08294 | -0.31258 | 0.14798 |
Procentu Izdevumi (Ienākumi) - Neto Darbība | 1.645 |
- Ikgadējs
- Ceturkšņa
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 103.498 | 94.254 | 103.951 | 208.107 | 230.851 |
Nauda un Īstermiņa Ieguldījumi | 36.81 | 20.786 | 42.107 | 110.949 | 128.089 |
Nauda un Ekvivalenti | 36.81 | 20.786 | 42.107 | 110.949 | 126.884 |
Īstermiņa Ieguldījumi | 0 | 1.205 | |||
Debitoru Parādu Kopsumma, Neto | 44.361 | 44.35 | 43.544 | 37.211 | 72.482 |
Accounts Receivable - Trade, Net | 44.361 | 44.35 | 43.257 | 37.211 | 72.482 |
Total Inventory | 7.489 | 11.712 | 3.412 | 3.396 | 13.042 |
Prepaid Expenses | 14.838 | 17.406 | 14.888 | 56.551 | 17.238 |
Total Assets | 326.547 | 303.274 | 527.17 | 932.866 | 1038.62 |
Property/Plant/Equipment, Total - Net | 2.262 | 4.784 | 6.273 | 13.064 | 13.024 |
Property/Plant/Equipment, Total - Gross | 14.011 | 15.57 | 18.143 | 23.837 | 26.945 |
Accumulated Depreciation, Total | -11.749 | -10.786 | -11.87 | -10.773 | -13.921 |
Intangibles, Net | 216.054 | 200.082 | 400.535 | 692.099 | 793.873 |
Other Long Term Assets, Total | 3.154 | 2.575 | 2.247 | 7.812 | 0.869 |
Total Current Liabilities | 135.019 | 132.686 | 184.553 | 246.036 | 310.58 |
Accounts Payable | 6.685 | 14.808 | 16.193 | 6.138 | 14.732 |
Accrued Expenses | 69.339 | 99.161 | 88.36 | 118.765 | 209.544 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 46.821 | 6.775 | 1.133 | 3.804 | |
Total Liabilities | 224.133 | 247.76 | 469.212 | 712.531 | 869.109 |
Total Long Term Debt | 61.319 | 72.16 | 271.258 | 446.107 | 544.23 |
Long Term Debt | 61.319 | 72.16 | 271.258 | 446.107 | 544.23 |
Other Liabilities, Total | 27.795 | 42.914 | 13.401 | 20.388 | 14.299 |
Total Equity | 102.414 | 55.514 | 57.958 | 220.335 | 169.508 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.004 | 0.013 | 0.008 | 0.006 | 0.006 |
Additional Paid-In Capital | 531.636 | 483.446 | 457.751 | 402.934 | 389.015 |
Retained Earnings (Accumulated Deficit) | -429.226 | -427.945 | -399.801 | -182.6 | -219.508 |
Other Equity, Total | 0 | -0.005 | -0.005 | ||
Total Liabilities & Shareholders’ Equity | 326.547 | 303.274 | 527.17 | 932.866 | 1038.62 |
Total Common Shares Outstanding | 44.6404 | 28.3922 | 20.222 | 16.0463 | 15.8501 |
Long Term Investments | 1.579 | 1.579 | 13.064 | 11.784 | 0 |
Current Port. of LT Debt/Capital Leases | 12.174 | 11.942 | 80 | 120 | 82.5 |
Note Receivable - Long Term | 1.1 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 125.115 | 103.498 | 112.545 | 119.348 | 124.069 |
Nauda un Īstermiņa Ieguldījumi | 61.389 | 36.81 | 58.726 | 54.428 | 61.033 |
Nauda un Ekvivalenti | 61.389 | 36.81 | 58.726 | 54.428 | 61.033 |
Debitoru Parādu Kopsumma, Neto | 48.923 | 44.361 | 36.145 | 45.468 | 39.241 |
Accounts Receivable - Trade, Net | 48.923 | 44.361 | 36.145 | 45.368 | 38.915 |
Total Inventory | 9.48 | 7.489 | 5.481 | 6.617 | 8.93 |
Prepaid Expenses | 5.323 | 14.838 | 12.193 | 12.835 | 14.865 |
Total Assets | 339.135 | 326.547 | 299.305 | 312.016 | 325.424 |
Property/Plant/Equipment, Total - Net | 1.915 | 2.262 | 2.59 | 2.969 | 2.172 |
Property/Plant/Equipment, Total - Gross | 13.126 | 14.011 | 14.134 | 14.277 | 13.222 |
Accumulated Depreciation, Total | -11.211 | -11.749 | -11.544 | -11.308 | -11.05 |
Intangibles, Net | 207.554 | 216.054 | 179.143 | 186.318 | 193.536 |
Other Long Term Assets, Total | 2.972 | 3.154 | 3.448 | 1.802 | 5.647 |
Total Current Liabilities | 138.527 | 135.019 | 100.48 | 116.914 | 109.09 |
Accounts Payable | 8.523 | 6.685 | 7.666 | 16.483 | 10.609 |
Accrued Expenses | 72.175 | 69.339 | 64.057 | 72.058 | 76.743 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 12.271 | 12.174 | 12.257 | 12.222 | 12.338 |
Other Current Liabilities, Total | 45.558 | 46.821 | 16.5 | 16.151 | 9.4 |
Total Liabilities | 227.273 | 224.133 | 202.445 | 219.751 | 220.121 |
Total Long Term Debt | 61.25 | 61.319 | 66.41 | 66.751 | 71.834 |
Long Term Debt | 61.25 | 61.319 | 66.41 | 66.751 | 71.834 |
Other Liabilities, Total | 27.496 | 27.795 | 35.555 | 36.086 | 39.197 |
Total Equity | 111.862 | 102.414 | 96.86 | 92.265 | 105.303 |
Common Stock | 0.004 | 0.004 | 0.004 | 0.004 | 0.018 |
Additional Paid-In Capital | 532.02 | 531.636 | 530.689 | 529.831 | 528.686 |
Retained Earnings (Accumulated Deficit) | -420.162 | -429.226 | -433.833 | -437.57 | -423.401 |
Total Liabilities & Shareholders’ Equity | 339.135 | 326.547 | 299.305 | 312.016 | 325.424 |
Total Common Shares Outstanding | 45.3354 | 44.6404 | 44.6225 | 44.494 | 43.4359 |
Long Term Investments | 1.579 | 1.579 | 1.579 | 1.579 |
- Ikgadējs
- Ceturkšņa
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | -1.281 | -28.144 | -217.201 | 36.908 | -102.496 |
Nauda no Darbības | 5.523 | -65.572 | 90.475 | 72.497 | 62.167 |
Nauda no Darbības | 29.077 | 26.431 | 102.946 | 106.426 | 105.502 |
Deferred Taxes | 0 | 0 | |||
Bezskaidras Naudas Preces | 9.02 | -19.647 | 205.336 | 36.361 | 40.823 |
Cash Taxes Paid | 0 | 1.136 | 4.401 | 6.472 | 0.121 |
Samaksātie Procenti Naudā | 10.124 | 17.598 | 37.788 | 48.44 | 55.542 |
Izmaiņas Apgrozāmajā Kapitālā | -31.293 | -44.212 | -0.606 | -107.198 | 18.338 |
Nauda no Ieguldījumu Darbībām | -18.525 | 512.801 | -1.481 | -7.082 | 57.894 |
Kapitālie Izdevumi | -0.053 | -0.01 | -1.481 | -5.507 | -0.666 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -18.472 | 512.811 | 0 | -1.575 | 58.56 |
Nauda no Darbībām ar Finansēšanu | 29.026 | -468.55 | -157.836 | -81.35 | -110.886 |
Naudas Plūsma Finansēšanas Posteņos | -6.193 | -4.382 | -8.087 | -0.87 | -9.826 |
Akciju Izsniegšana (Atkāpšanās), Neto | 45.054 | 0.088 | 0.251 | 2.02 | 8.94 |
Parādu Izsniegšana (Atkāpšanās), Neto | -9.835 | -464.256 | -150 | -82.5 | -110 |
Neto Izmaiņas Naudā | 16.024 | -21.321 | -68.842 | -15.935 | 9.175 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 9.064 | -1.281 | -5.887 | -9.625 | 4.544 |
Cash From Operating Activities | 27.426 | 5.523 | 1.392 | -3.262 | -4.226 |
Cash From Operating Activities | 8.699 | 29.077 | 21.698 | 14.286 | 6.812 |
Non-Cash Items | 2.686 | 9.02 | 4.571 | 3.589 | 0.4 |
Cash Taxes Paid | -8.36 | 0 | 0 | 0 | 0 |
Cash Interest Paid | 0 | 10.124 | 5.216 | 5.216 | 0 |
Changes in Working Capital | 6.977 | -31.293 | -18.99 | -11.512 | -15.982 |
Cash From Investing Activities | -0.404 | -18.525 | 0 | 0 | 0 |
Capital Expenditures | -0.053 | 0 | 0 | 0 | |
Cash From Financing Activities | -2.443 | 29.026 | 36.548 | 36.904 | 44.473 |
Financing Cash Flow Items | -2.443 | -6.193 | -3.421 | -3.4 | -0.388 |
Issuance (Retirement) of Stock, Net | 0 | 45.054 | 45.054 | 45.054 | 44.861 |
Issuance (Retirement) of Debt, Net | -9.835 | -5.085 | -4.75 | 0 | |
Net Change in Cash | 24.579 | 16.024 | 37.94 | 33.642 | 40.247 |
Other Investing Cash Flow Items, Total | -0.404 | -18.472 | 0 | 0 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.9481 | 2194270 | 82994 | 2022-12-31 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 2.0623 | 1146213 | -430209 | 2022-12-31 | MED |
Bridgeway Capital Management, LLC | Investment Advisor | 1.7017 | 945800 | 150000 | 2022-12-31 | LOW |
Littlejohn & Co. LLC | Private Equity | 1.7015 | 945677 | 0 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 1.6923 | 940574 | -108092 | 2022-12-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.6616 | 923478 | 40771 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.5664 | 870598 | 579484 | 2022-12-31 | HIGH |
Renaissance Technologies LLC | Hedge Fund | 1.4893 | 827735 | 121200 | 2022-12-31 | HIGH |
Friess Associates LLC | Investment Advisor | 1.3794 | 766650 | -429802 | 2022-06-30 | |
First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 1.238 | 688075 | 188076 | 2022-12-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.2029 | 668534 | -205846 | 2022-12-31 | HIGH |
D. E. Shaw & Co., L.P. | Hedge Fund | 0.9001 | 500252 | 21076 | 2022-12-31 | MED |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.8065 | 448219 | 179565 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7642 | 424731 | 8124 | 2022-12-31 | LOW |
Tekla Capital Management LLC | Investment Advisor | 0.7387 | 410575 | 0 | 2022-12-31 | LOW |
Perritt Capital Management, Inc. | Investment Advisor | 0.7313 | 406434 | 34334 | 2022-12-31 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.6667 | 370538 | -4283 | 2022-12-31 | LOW |
Peisert (Daniel A) | Individual Investor | 0.562 | 312364 | 153962 | 2023-02-11 | MED |
Citadel Advisors LLC | Hedge Fund | 0.5101 | 283507 | 907 | 2022-12-31 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.5076 | 282092 | -33340 | 2022-12-31 | MED |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group500K+
Tirgotāji
92K+
Ikmēneša aktīvie klienti
$53M+
Ikmēneša ieguldījumu apjoms
$30M+
Izņemts katru mēnesi
Treidinga kalkulators
Aprēķiniet iespējamo peļņu un zaudējumus, uzsākot CFD darījumu noteiktā dienā (izvēlaties datumu) un slēdzot darījumu citā dienā (izvēlaties datumu).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Assertio Holdings, Inc. Company profile
Par Assertio Holdings, Inc.
Assertio Holdings, Inc. ir specializēts farmācijas uzņēmums, kas piedāvā diferencētus produktus pacientiem, izmantojot bezpersonisku reklāmas modeli. Uzņēmuma galvenie tirgotie produkti ir INDOCIN (indometacīns) svecītes, INDOCIN (indometacīns) perorālā suspensija, INDOCIN (indometacīns) perorālā suspensija, CAMBIA (diklofenaka kālija šķīdums iekšķīgai lietošanai), Otrexup (metotreksāts) injekcija zemādas lietošanai, SPRIX (ketorolaka trometamīns) deguna aerosols un Zipsor (diklofenaka kālija šķīdums) kapsulas ar šķidrumu. Uzņēmumam ir arī citi komerciāli pieejami produkti, tostarp OXAYDO (oksikodona HCI, USP) tabletes tikai iekšķīgai lietošanai. Assertio un Zyla ir uzņēmuma reģistrētas preču zīmes. INDOCIN produktus lieto vidēji smaga līdz smaga reimatoīdā artrīta, tostarp hroniskas slimības akūtu paasinājumu, vidēji smaga līdz smaga ankilozējošā spondilīta, vidēji smaga līdz smaga osteoartrīta, akūta sāpīga pleca (bursīta un/vai tendinīta) un akūta podagras artrīta ārstēšanai.
Industry: | Pharmaceuticals (NEC) |
100 S. Saunders Road
Suite 300
LAKE FOREST
ILLINOIS 60045
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com